Panmyelopathy following use of Daraprim in therapy of toxoplasmosis
Sfetsos, M.
Medizinische Klinik 65(21): 1039-1042
1970
ISSN/ISBN: 0025-8458 PMID: 5522186 Document Number: 27808
Document emailed within 1 workday
Related Documents
Armata, J.; Wyszkowski, J.; Krop, J. 1972: Daraprim in leukemia of the central nervous system in children Polski Tygodnik Lekarski 27(48): 1895-1897Jorke, D.; Bach, G. 1986: Panmyelopathy and myeloproliferative syndrome Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 41(21): 595-598
Slunsky, R.; Kiss, G. 1971: Labor and hemostasis in panmyelopathy Zentralblatt für Gynakologie 93(5): 145-148
Liechti, D.; Batz, K.; Bucher, U. 1970: Panmyelopathy with hyperplastic bone marrow Revue Medicale de la Suisse Romande 90(3): 227-246
Schulz, K.; Nowotny, P.; Konrad, H.; Preussner, S.; Kiencke, H. 1970: Studies on the genesis of anemia in patients suffering from panmyelopathy Das Deutsche Gesundheitswesen 25(25): 1152-1156
Hervei, S.; Simon, K. 1979: Congenital toxoplasmosis simulating brain tumor. Serologic properties, preventive possibilities in toxoplasmosis Orvosi Hetilap 120(29): 1767-1772
Asatova, M.M.; Avdiukhina, T.I.; Gobunova, I.P. 1993: The results of a serological examination of the population for toxoplasmosis and the estimated incidences of congenital toxoplasmosis in 2 foci in Uzbekistan Meditsinskaia Parazitologiia i Parazitarnye Bolezni 2: 25-27
Russo, M. 1994: Toxoplasmosis in pregnancy. Prevention, diagnosis, and therapy Recenti Progressi in Medicina 85(1): 37-48
Nemec, R.; Catár, G.; Holková, R.; Porubenová, A.; Pavlína, M. 1987: Use of the microprecipitation reaction in the diagnosis and therapy of toxoplasmosis Bratislavske Lekarske Listy 88(3): 330-335
Sánchez Fayos, J.; Lasierra Cirujeda, J. 1984: Chronic granulocytic leukemia as a proliferative panmyelopathy of a clonal nature Sangre 29(4-B): 491-501
Prásil, P. 2009: Current options for the diagnosis and therapy of toxoplasmosis in HIV-negative patients Klinicka Mikrobiologie a Infekcni Lekarstvi 15(3): 83-90
1970: Toxoplasmosis during pregnancy and prevention of congenital toxoplasmosis La Presse Medicale 78(14): 665
Averina, N.I. 1971: Complex delagil and sulfadimezin therapy in persons with acquired chronic toxoplasmosis Vrachebnoe Delo 5: 147-149
García-Bujalance, S.; Ocampo Sánchez, A.; Ladrón De Guevara García, C. 2002: Toxoplasmosis after antineoplastic therapy in non-Hodgkin lymphoma. Demand of preventive measures Revista Clinica Espanola 202(3): 148-151
Anghel, G. 2002: Clinical and therapy features of ocular toxoplasmosis in patients with HIV-AIDS infection Oftalmologia 53(2): 93-96
Lebenzon, S.S.; Fridliand, K.I. 1978: Plaque formation reaction as a criterion to evaluate the effectiveness of desensitization therapy in toxoplasmosis Meditsinskaia Parazitologiia i Parazitarnye Bolezni 47(5): 59-61
Germer, W.D. 1977: Current therapy of clinically manifested toxoplasmose in adults. Is there the possibility of active immunization against toxoplasmosis? Die Medizinische Welt 28(43): 1778
Heimpel, H. 1980: Pro and con: Panmyelopathy: stem cell or autoimmune disease. Arguments for a disease of hemopoietic stem cells Der Internist 21(7): 354-356
Sato, T. 1971: Studies on the ocular toxoplasmosis. 3. Analytical studies on cases of ocular toxoplasmosis Nippon Ganka Gakkai Zasshi 75(2): 1062-1069
Bonardi, R. 1980: Toxoplasmosis Minerva Medica 71(4): 297-300